These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9247391)

  • 1. Durable power of attorney and informed consent with Alzheimer's disease patients: a clinical study.
    Dukoff R; Sunderland T
    Am J Psychiatry; 1997 Aug; 154(8):1070-5. PubMed ID: 9247391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.
    Kim SY; Caine ED; Currier GW; Leibovici A; Ryan JM
    Am J Psychiatry; 2001 May; 158(5):712-7. PubMed ID: 11329391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed consent with cognitively impaired patients: an NIMH perspective on the durable power of attorney.
    Sunderland T; Dukoff R
    Account Res; 1996; 4(3-4):217-26. PubMed ID: 11654517
    [No Abstract]   [Full Text] [Related]  

  • 4. Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research.
    Kim SY; Cox C; Caine ED
    Am J Psychiatry; 2002 May; 159(5):797-802. PubMed ID: 11986134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological and legal aspects of mental incompetence.
    Ahmed MB
    Tex Med; 1998 Mar; 94(3):64-7. PubMed ID: 9529970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.
    Zubenko GS; Zubenko WN; McPherson S; Spoor E; Marin DB; Farlow MR; Smith GE; Geda YE; Cummings JL; Petersen RC; Sunderland T
    Am J Psychiatry; 2003 May; 160(5):857-66. PubMed ID: 12727688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.
    Stern RG; Mohs RC; Davidson M; Schmeidler J; Silverman J; Kramer-Ginsberg E; Searcey T; Bierer L; Davis KL
    Am J Psychiatry; 1994 Mar; 151(3):390-6. PubMed ID: 8109647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advance consent for dementia research.
    Sachs GA
    Alzheimer Dis Assoc Disord; 1994; 8(Suppl. 4):19-27. PubMed ID: 11657670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obtaining informed consent in Alzheimer's research.
    Resau LS
    J Neurosci Nurs; 1995 Feb; 27(1):57-60. PubMed ID: 7769331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Views of potential subjects toward proposed regulations for clinical research with adults unable to consent.
    Wendler D; Martinez RA; Fairclough D; Sunderland T; Emanuel E
    Am J Psychiatry; 2002 Apr; 159(4):585-91. PubMed ID: 11925296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.
    Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL
    Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the degree of cognitive impairment in patients with Alzheimer's disease related to their capacity to appoint an enduring power of attorney?
    Gregory R; Roked F; Jones L; Patel A
    Age Ageing; 2007 Sep; 36(5):527-31. PubMed ID: 17913758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable power of attorney versus the advance directive: who wins, who suffers?
    Baumrucker SJ
    Am J Hosp Palliat Care; 2007; 24(1):68-73. PubMed ID: 17347510
    [No Abstract]   [Full Text] [Related]  

  • 14. Research advance directives: protection or obstacle?
    Muthappan P; Forster H; Wendler D
    Am J Psychiatry; 2005 Dec; 162(12):2389-91. PubMed ID: 16330609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proxy decision making in Alzheimer disease research: durable powers of attorney, guardianship, and other alternatives.
    Kapp MB
    Alzheimer Dis Assoc Disord; 1994; 8(Suppl. 4):28-37. PubMed ID: 11657671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.
    Modrego PJ; Ferrández J
    Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the completion of the durable power of attorney for health care. A randomized, controlled trial.
    Rubin SM; Strull WM; Fialkow MF; Weiss SJ; Lo B
    JAMA; 1994 Jan; 271(3):209-12. PubMed ID: 8277547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate decision-making and related issues.
    Beck C; Shue V
    Alzheimer Dis Assoc Disord; 2003; 17 Suppl 1():S12-6. PubMed ID: 12813219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The capacity to vote of persons with Alzheimer's disease.
    Appelbaum PS; Bonnie RJ; Karlawish JH
    Am J Psychiatry; 2005 Nov; 162(11):2094-100. PubMed ID: 16263849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.